AU2003301900A1 - Antipruritic drug - Google Patents

Antipruritic drug

Info

Publication number
AU2003301900A1
AU2003301900A1 AU2003301900A AU2003301900A AU2003301900A1 AU 2003301900 A1 AU2003301900 A1 AU 2003301900A1 AU 2003301900 A AU2003301900 A AU 2003301900A AU 2003301900 A AU2003301900 A AU 2003301900A AU 2003301900 A1 AU2003301900 A1 AU 2003301900A1
Authority
AU
Australia
Prior art keywords
antipruritic drug
antipruritic
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003301900A
Other languages
English (en)
Inventor
Iwao Arai
Fumie Sato
Norikazu Takano
Tohru Tanami
Makoto Yagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of AU2003301900A1 publication Critical patent/AU2003301900A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
AU2003301900A 2002-11-13 2003-11-13 Antipruritic drug Abandoned AU2003301900A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002329980 2002-11-13
JP2002-329980 2002-11-13
PCT/JP2003/014446 WO2004043471A1 (fr) 2002-11-13 2003-11-13 Medicament antipruritique

Publications (1)

Publication Number Publication Date
AU2003301900A1 true AU2003301900A1 (en) 2004-06-03

Family

ID=32310586

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003301900A Abandoned AU2003301900A1 (en) 2002-11-13 2003-11-13 Antipruritic drug

Country Status (3)

Country Link
JP (1) JP4477504B2 (fr)
AU (1) AU2003301900A1 (fr)
WO (1) WO2004043471A1 (fr)

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
DE3325175A1 (de) * 1983-07-08 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen 11-halogen-prostanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3347128A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA1322197C (fr) * 1987-07-17 1993-09-14 Bernd Buchmann Derives 9-halogene-(z)-prostaglandine, procede pour leur production et leur utilisation comme agents pharmaceutiques
EP0652211A1 (fr) * 1992-07-24 1995-05-10 Taisho Pharmaceutical Co. Ltd Derive de prostaglandine
EP0666256A1 (fr) * 1992-10-20 1995-08-09 Taisho Pharmaceutical Co. Ltd Derive de prostaglandine
US6124344A (en) * 1993-12-28 2000-09-26 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
JP3579448B2 (ja) * 1993-12-29 2004-10-20 大正製薬株式会社 プロスタグランジン誘導体、その塩およびその使用
JP3573482B2 (ja) * 1994-03-07 2004-10-06 大正製薬株式会社 プロスタグランジン誘導体およびその使用
JP3506485B2 (ja) * 1994-04-19 2004-03-15 大正製薬株式会社 プロスタグランジン誘導体
US5807892A (en) * 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
WO1996016935A1 (fr) * 1994-11-30 1996-06-06 Taisho Pharmaceutical Co., Ltd. Derive de prostaglandines
JPH09286775A (ja) * 1996-04-24 1997-11-04 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
PT946155E (pt) * 1996-12-23 2006-07-31 Sla Pharma Ag Composicao farmaceutica para tratar incontinencia fecal e prurido anal
NO317155B1 (no) * 1997-02-04 2004-08-30 Ono Pharmaceutical Co <omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
JP2000044477A (ja) * 1998-05-25 2000-02-15 Taisho Pharmaceut Co Ltd てんかん治療剤
TWI249520B (en) * 1998-07-15 2006-02-21 Ono Pharmaceutical Co 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
JP2000273083A (ja) * 1999-03-19 2000-10-03 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
JP2001089443A (ja) * 1999-07-19 2001-04-03 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
DE60043702D1 (de) * 1999-09-10 2010-03-04 Taisho Pharmaceutical Co Ltd Prostaglandin-derivate
JP2001122786A (ja) * 1999-10-20 2001-05-08 Taisho Pharmaceut Co Ltd 睡眠誘発剤
JP2001151749A (ja) * 1999-11-24 2001-06-05 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
EP1245562A4 (fr) * 2000-01-05 2004-12-15 Ono Pharmaceutical Co Alcools 5-thia-"omega"-(phenyle substitues)- prostaglandine e, processus de preparation de ces alcools et preparations pharmaceutiques contenant ces alcools comme principe actif.
JP4929472B2 (ja) * 2000-08-22 2012-05-09 小野薬品工業株式会社 カルボン酸誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
CA2419722A1 (fr) * 2000-09-01 2003-02-21 Masaki Asada Derives d'acide benzoique et medicaments possedant ces derniers comme principe actif
MXPA04003851A (es) * 2002-02-22 2004-07-08 Taisho Pharmaceutical Co Ltd Antipruriticos.
AU2003254904A1 (en) * 2002-08-09 2004-02-25 Taisho Pharmaceutical Co., Ltd. Aryl 5-thio-beta-d-glucopyranoside derivatives and therapeutic agents for diabetes containing the same

Also Published As

Publication number Publication date
WO2004043471A1 (fr) 2004-05-27
JPWO2004043471A1 (ja) 2006-03-09
JP4477504B2 (ja) 2010-06-09

Similar Documents

Publication Publication Date Title
AU2002335152A1 (en) Robot-phone
AU2003215209A1 (en) Syringe
AU2003259457A1 (en) Auto-destructible syringe
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2002368348A1 (en) Electrosomatogram
AU2002318053A1 (en) Suplier
AU2002348964A1 (en) Snowbike
AU2002341221A1 (en) Honey-brandy
AU2003301900A1 (en) Antipruritic drug
AU2003268985A1 (en) Cannula
AU2002344387A1 (en) Multifunction-pillow
AU2003244272A1 (en) Segment
AU2002100031A4 (en) earliPay
AU2002100026A4 (en) Disc400
AU2002100957A4 (en) Sluggit
AU2002100739A4 (en) Neuramax
AU2002100160A4 (en) Oxidirator
AU2002100655A4 (en) Armamulch
AU2002100602A4 (en) Bonsystem
AU2002100541A4 (en) Backmate
AU2002100510A4 (en) Bottlenecker
AU2002100508A4 (en) Photocard
AU2002100498A4 (en) Linline
AU2002100482A4 (en) Tail-gate-ezy
AU2002100468A4 (en) Flexi-edger

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase